Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-181.46% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CTOR · Jun 30, 2026
CITIUS ONCOLOGY, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 1[email protected]
Inspectable configuration
State dimensions
Filing0001213900-26-090184General Corporate
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
1514.67% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
67.07% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-583.54% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
238.37% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History3 statesHistory building
Period transition
What moved in the state?
- Previous
- -229.81%
- Current
- -181.46%
- Delta
- 48.35%
- Previous
- 1359.06%
- Current
- 1514.67%
- Delta
- 155.61%
- Previous
- 80.27%
- Current
- 67.07%
- Delta
- -13.20%
- Previous
- -1716.17%
- Current
- -583.54%
- Delta
- 1132.63%
- Previous
- 64.74%
- Current
- 14.63%
- Delta
- -50.11%
- Previous
- 211.52%
- Current
- 238.37%
- Delta
- 26.85%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Transitioned To · CTOR Fundamental State →Transitioned To · CTOR CASH_GENERATION_INCREASED →Transitioned To · CTOR INVENTORY_PRESSURE_INCREASED →Transitioned To · CTOR MARGIN_DECREASED →Transitioned To · CTOR PROFITABILITY_INCREASED →Transitioned To · CTOR R_AND_D_INTENSITY_DECREASED →Transitioned To · CTOR SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.